156 related articles for article (PubMed ID: 35985772)
1. Identification and analytical characterization of N-propyl norbutylone, N-butyl norbutylone, N-benzyl norheptedrone, and N-pyrrolidinyl-3,4-DMA.
Liu CM; Hua ZD; Song CH; Jia W
Drug Test Anal; 2023 Jan; 15(1):47-57. PubMed ID: 35985772
[TBL] [Abstract][Full Text] [Related]
2. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP.
Liu C; Jia W; Li T; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1162-1171. PubMed ID: 27863142
[TBL] [Abstract][Full Text] [Related]
3. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
Liu C; Jia W; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
[TBL] [Abstract][Full Text] [Related]
4. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
5. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs.
Zuba D; Sekuła K
Drug Test Anal; 2013 Aug; 5(8):634-45. PubMed ID: 22936468
[TBL] [Abstract][Full Text] [Related]
6. Identification of AD-18, 5F-MDA-19, and pentyl MDA-19 in seized materials after the class-wide ban of synthetic cannabinoids in China.
Liu CM; Hua ZD; Jia W; Li T
Drug Test Anal; 2022 Feb; 14(2):307-316. PubMed ID: 34694738
[TBL] [Abstract][Full Text] [Related]
7. [Identification of New Psychoactive Tryptamines 4-OH-MET and 4-AcO-DMT Using High Resolution Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy].
Ding KR; Ni CF; He SY; Wang KD; Deng QY; Liang C
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):511-515. PubMed ID: 34726004
[TBL] [Abstract][Full Text] [Related]
8. The identification and analytical characterization of 2,2'-difluorofentanyl.
Liu C; Li T; Han Y; Hua Z; Jia W; Qian Z
Drug Test Anal; 2018 Apr; 10(4):774-780. PubMed ID: 28851108
[TBL] [Abstract][Full Text] [Related]
9. Identification of five pyrrolidinyl substituted cathinones and the collision-induced dissociation of electrospray-generated pyrrolidinyl substituted cathinones.
Qian Z; Jia W; Li T; Hua Z; Liu C
Drug Test Anal; 2017 May; 9(5):778-787. PubMed ID: 27367446
[TBL] [Abstract][Full Text] [Related]
10. Identification of the New Psychoactive Substance Eutylone.
Deng QY; Sun WJ; He SY; Wang KD; Chen YS; Wang W; Liang C
Fa Yi Xue Za Zhi; 2022 Aug; 38(4):473-477. PubMed ID: 36426690
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
[TBL] [Abstract][Full Text] [Related]
12. Identification of three novel new psychoactive substances 4F-AB-BUTINACA, AB-PHETINACA, and 2F-NENDCK.
Wang KD; Yuan XL; Liu C; Cao FQ; Zhang YR; Liu WB; He SY
Drug Test Anal; 2023 Jan; 15(1):115-122. PubMed ID: 35986510
[TBL] [Abstract][Full Text] [Related]
13. [Structure Analysis and Characterization of Aminorex Analogue 4'-F-4-MAR].
Liu CM; Hua ZD; Jia W
Fa Yi Xue Za Zhi; 2020 Oct; 36(5):677-681. PubMed ID: 33295170
[TBL] [Abstract][Full Text] [Related]
14. Identification and analytical characterization of four synthetic cannabinoids ADB-BICA, NNL-1, NNL-2, and PPA(N)-2201.
Qian Z; Jia W; Li T; Hua Z; Liu C
Drug Test Anal; 2017 Jan; 9(1):51-60. PubMed ID: 27239006
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
[TBL] [Abstract][Full Text] [Related]
16. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectral Character of Fentanyl Analogues.
Yan J; Hua ZD; Jia W; Liu CM
Fa Yi Xue Za Zhi; 2019 Apr; 35(2):216-223. PubMed ID: 31135118
[TBL] [Abstract][Full Text] [Related]
18. Identification of ADB-5'Br-BINACA in plant material and analytical characterization using GC-MS, LC-QTOF-MS, NMR and ATR-FTIR.
de Campos EG; Farrar DG; Krotulski AJ
J Pharm Biomed Anal; 2024 Sep; 247():116254. PubMed ID: 38810333
[TBL] [Abstract][Full Text] [Related]
19. Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and NMR as part of a police investigation of a Danish internet company.
Reitzel LA; Dalsgaard PW; Müller IB; Cornett C
Drug Test Anal; 2012 May; 4(5):342-54. PubMed ID: 22102551
[TBL] [Abstract][Full Text] [Related]
20. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
